According to two groups in the United States, 70% of all the cases of chronic graft-versus-host disease were resulting from patients that already had suffered from acute graft-versus-host disease. So, 30% appears to be primary. I do not know whether this is a very slowly developing graft-versus-host disease, or that it is a new syndrome.
Unable to display preview. Download preview PDF.
- Meunier-Carpentier F, Snoeck R, Ceuppens AM, Klastersky J. Treatment of oropharyngeal candidiasis in cancer patients. In: Proceedings of the 13th International Congress of Chemotherapy, part 40. Antifungal therapy with ketoconazole. Vienna 1983.Google Scholar
- Singal DP, Joseph S, Szewczuk MR. Possible mechanisms of the beneficial sffect of pretransplant blood transfusion on renal allograft survival in man. Transplant Proc 1982; XIV: 316–8.Google Scholar